Clinical Trial Update: A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether 2% lidocaine gel reduces discomfort during urethral catheterization in patients with urinary tract infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Lidocaine Gel 2% (lidocaine 2% gel)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Urinary Tract Infection | Phase 2 | Status: COMPLETED